Presentation TCT 2024 TCT 255: Identifying Patients With Stable Ischemic Cardiomyopathy Whose LVEF Will Increase After PCI Presenter: Stephen Ellis October 29, 2024
Presentation TCT 2024 TCT 254: Importance of Change in LVEF with PCI on Risk of Cardiac Death or Hospitalization for Heart Failure in Pateients With Stable Ischemic Cardiomyopathy Presenter: Stephen Ellis October 29, 2024
Presentation TCT 2024 TCT 253: Percutaneous Coronary Intervention Outcomes by Race and Ethnicity: A Large Single-Center Experience Presenter: Arjun Kapoor October 29, 2024
Presentation TCT 2024 TCT 251: Practice Patterns and Percutaneous Coronary Intervention Outcomes in University Hospitals: A Comparison Between Sweden and the U.S. Presenter: Revathy Sampath-Kumar October 29, 2024
Presentation TCT 2024 TCT 250: Temporal Trends in Ischemic Heart Disease-related Mortality in Canada Over the Past 3 Decades Presenter: Ahmed Abdulelah October 29, 2024
Presentation TCT 2024 TCT 658: Physiological CAD Pattern as Assessed by Angiography Pull Back Pressure Gradient Index in Vessels With Fractional Flow Reserve and Instantaneous Wave-Free Ratio Discordance Presenter: Pruthvi C Revaiah October 29, 2024
Presentation TCT 2024 TCT 832: Impact of Coronary Artery Disease and Revascularization on Clinical and Health Status Outcomes After TAVR: Results From the STS/ACC TVT Registry Presenter: Yasser Sammour October 29, 2024
Presentation TCT 2024 TCT 831: Outcomes Following Balloon Aortic Valvuloplasty Facilitated Impella® Support for Percutaneous Coronary Intervention in Patients With Severe Aortic Stenosis as a Bridge to TAVR Presenter: Arjun Kapoor October 29, 2024
Presentation TCT 2024 TCT 830: Feasibility and Utility of Anatomical and Physiological Evaluation of Coronary Disease With Cardiac CT in Severe Aortic Stenosis (FUTURE-AS Registry) Presenter: Abdul Rahman Ihdayhid October 29, 2024
Presentation TCT 2024 TCT 829: Safety of Ruling Out Coronary Artery Disease by Computed Tomography Angiography Before Transcatheter Aortic Valve Replacement Presenter: Asa Phichaphop October 29, 2024
Presentation TCT 2024 TCT 828: Natural History of Coronary Artery Disease After Transcatheter Aortic Valve Implantation Presenter: Kalyan Chitturi October 29, 2024
Presentation TCT 2024 TCT 827: Rationale and Design of the Randomized Controlled PRO-TAVI Trial Presenter: Hugo Aarts October 29, 2024
Presentation TCT 2024 TCT 18: The Impact of Coronary Physiology on the Initial Treatment Strategy for Percutaneous Coronary Intervention: Insights From FAVOR III China Trial Presenter: Hao-Yu Wang October 29, 2024
Presentation TCT 2024 TCT 16: Intracoronary Near-Infrared Spectroscopy to Predict No-Reflow Phenomenon During Percutaneous Coronary Intervention in Acute Coronary Syndrome Presenter: Yuichi Ozaki October 29, 2024
Presentation TCT 2024 TCT 14: Prevalence and Impact of Standard Modifiable Risk Factors Among Patients Undergoing Percutaneous Coronary Intervention Presenter: Johny Nicolas October 29, 2024
Presentation TCT 2024 TCT 13: Chinese Visceral Adiposity Index Is Associated With the Occurrence of Cardiovascular Disease Among Middle-Aged and Older People in China Presenter: Rongchong Huang October 29, 2024
Presentation TCT 2024 TCT 725: Relationship Between Diffuse or Focal CAD Patterns and the Seattle Angina Questionnaire (SAQ) at 2-Year Follow-Up Presenter: KOTARO MIYASHITA October 29, 2024
Presentation TCT 2024 TCT 243: Overweight Followed by Obesity and Morbid Obesity Have the Lowest Mortality, Whereas Cachexia Has the Highest Mortality Compared to Normal Weight Category in Patients Undergoing PCI Presenter: Mohammad Reza Movahed October 28, 2024
Presentation TCT 2024 TCT 242: Prospective Validation of the ARC-HBR, PRECISE-DAPT, and PARIS Risk Prediction Model in the All-Comer PIONEER IV Trial Presenter: TsungYing Tsai October 28, 2024
Presentation TCT 2024 TCT 241: Elective General Anesthesia for Patients Undergoing Complex and High-risk Intervention in Indicated Patients (CHIP) Percutaneous Coronary Interventions Presenter: Julio Farjat Pasos October 28, 2024